Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
PrEP drug patent overturned in UK - NAT respond

The High Court has today overturned Gilead's patent extension on Truvada, the HIV drug also used in PrEP.

Published
3 hours ago
From
National AIDS Trust
Do-it-yourself HIV prevention: who do men buying PrEP online get support from?

Gay men in London who source their own supply of generic pre-exposure prophylaxis (PrEP) drugs, usually from overseas internet pharmacies, most often learnt about this possibility from

Published
12 hours ago
By
Roger Pebody
Scotland: Women’s group discuss PrEP

In the first eight months that PrEP was available on the NHS in Scotland, only 10 out of 1,295 people to access the HIV prevention drug were women. Our women’s group in Edinburgh recently met up with Dr Ingrid Young of Edinburgh University, as part of research work to understand the barriers that women face accessing PrEP, and how this access could be widened.

Published
14 September 2018
From
Waverley Care
Northern Ireland: New HIV clinic to offer access to PrEP drug

A new HIV prevention clinic is to transform how HIV services are delivered to people in Northern Ireland. It will provide comprehensive testing for sexual transmitted infections and offer access to the HIV prevention drug, PrEP.

Published
12 September 2018
From
BBC
CJEU Ruling on Truvada recalls ‘evergreening’ goes against public health interests

On 25th July 2018, the Court of Justice of the European Union (CJEU) rendered its preliminary ruling on the interpretation of Article 3(a) of Regulation (EC) No 469/2009 concerning the supplementary protection certificate (SPC) for medicinal products.

Published
10 September 2018
From
Medicines Law & Policy
Starting from here – what PrEP programmes can learn from circumcision

Funders, health providers and advocates should take lessons from the rollout of voluntary medical male circumcision (VMMC) as an HIV prevention measure in Africa if they wish

Published
10 September 2018
By
Gus Cairns
As HIV Rates Decline, A Surprising Population Is Seeing A Rise In Diagnoses In Major Cities

But new efforts to educate at-risk women about a drug that helps protect against the virus could change that.

Published
05 September 2018
From
Huffington Post
HIV Providers and Advocates Continue to Debate STI Rates in the Era of PrEP and U=U

From Aug. 27 to 30, the Centers for Disease Control and Prevention (CDC)'s Division of Sexually Transmitted Disease (STD) Prevention will host the STD Prevention Conference in Washington, D.C. This biennial conference could not be timelier as the U.S. is facing a resurgence in sexually transmitted infections (STIs).

Published
03 September 2018
From
The Body Pro
Alberta Announces Coverage For HIV Prevention Drug PrEP Starting Oct. 1

Several other provinces currently cover PrEP under their health plans, including B.C., Saskatchewan, Ontario, Quebec, Nova Scotia and New Brunswick. Coverage in Alberta will begin on Oct. 1 and will require a doctor's prescription.

Published
03 September 2018
From
HuffPost Canada
One in three women in US survey have negative attitudes towards PrEP

A survey conducted by Planned Parenthood in the US state of Connecticut has found that although less than a quarter of women attending their clinics were aware of

Published
31 August 2018
By
Gus Cairns
← First12345...147Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.